The Japanese pharma industry experienced a 34% drop in new job postings in Q2 2023 compared with the previous quarter, with the highest share accounted for by Takeda Pharmaceutical with 186 job postings according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharmaceutical Drugs Development Annual Review provides a comprehensive analysis of the pharmaceutical industry in 2022, focusing on drug development trends, future opportunities and key movements in regulatory, clinical, and market aspects. Buy the report here.
Notably, Management Occupations jobs accounted for a 29% share of the Japanese’s pharma industry new job postings in Q2 2023, down by 34% over the prior quarter.
Management Occupations drive pharma hiring activity
Of the industry's total hiring activity, the highest number of new job postings were for Management Occupations, which accounted for 29% of the total new job postings in Q2 2023 and were down by 14% year-on-year. Second highest were Life, Physical, and Social Science Occupations, which accounted for 7% and flat growth by 0% year-on-year, and third highest were Business and Financial Operations Occupations, which were 16% of the new job postings and 6% higher year-on-year.
Top five companies in pharma accounted for 47% of hiring activity
The highest number of jobs were posted by Takeda Pharmaceutical with 186, followed by Novartis with 117, while the highest increase was at Novo Nordisk at 100%.
For further understanding of GlobalData's Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.